GlassScriptPhysician profile
Robert J Subbiondo
NPI 1467449017
$6,339.94
in general payments reported to CMS, 2019-2025
39 companies · $1,731 in 2025
The $1,731 reported for 2025 was more than what 81% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $826 · 2020: $723 · 2021: $497 · 2022: $987 · 2023: $693 · 2024: $883 · 2025: $1,731.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,307.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,307.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $651.40 | 2019-2025 | Farxiga, Wainua |
| Amgen INC. | $617.00 | 2019-2025 | Repatha, Repatha |
| Merck Sharp & Dohme LLC | $601.29 | 2021-2025 | Verquvo, Capvaxive |
| Boston Scientific Corporation | $466.43 | 2019-2025 | Watchman Flx, Watchman Access System, Farapulse |
| Janssen Pharmaceuticals, INC | $428.99 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $371.03 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $356.98 | 2019-2025 | Jardiance |
| Pfizer INC. | $322.89 | 2019-2025 | |
| Cvrx, INC. | $311.81 | 2021-2025 | Barostim Neo System |
| Abbott Laboratories | $282.17 | 2020-2025 | Triclip, Cardiomems, Aveir |
| Philips North America LLC | $266.72 | 2022-2025 | (Ck7) Extended Holter, (Ck6) Holter, Extended Holter |
| Alnylam Pharmaceuticals INC. | $264.72 | 2022-2025 | Onpattro |
| Actelion Pharmaceuticals US, INC. | $158.17 | 2024-2025 | Uptravi, Opsumit |
| Astellas Pharma US INC | $157.93 | 2019 | |
| Sanofi-Aventis U.S. LLC | $142.26 | 2019-2022 |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Subbiondo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.